Health status and costs of ambulatory patients with multiple sclerosis in Hungary

Márta Péntek, L. Gulácsi, C. Rózsa, Magdolna Simó, Anna Iljicsov, S. Komoly, Valentin Brodszky

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background and purpose - Data on disease burden of multiple sclerosis from Eastern-Central Europe are very limited. Our aim was to explore the quality of life, resource utilisation and costs of ambulating patients with multiple sclerosis in Hungary. Methods - Cross-sectional questionnaire survey was performed in two outpatient neurology centres in 2009. Clinical history, health care utilisation in the past 12 months were surveyed, the Expanded Disability Status Scale and the EQ-5D questionnaires were applied. Cost calculation was conducted from the societal perspective. Results - Sixty-eight patients (female 70.6%) aged 38.0 (SD 9.1) with disease duration of 7.8 (SD 6.7) years were involved. Fifty-five (80.9%) had relapsing-remitting form and 52 (76.5%) were taking immunomodulatory drug. The average scores were: Expanded Disability Status Scale 1.9 (SD 1.7), EQ-5D 0.67 (SD 0.28). Mean total cost amounted to 10 902 Euros/patient/year (direct medical 67%, direct non-medical 13%, indirect costs 20%). Drugs, disability pension and informal care were the highest cost items. Costs of mild (Expanded Disability Status Scale 0-3.5) and moderate (Expanded Disability Status Scale 4.0-6.5) disease were 9 218 and 17 634 Euros/patient/year respectively (p

Original languageEnglish
Pages (from-to)316-324
Number of pages9
JournalIdeggyógyászati szemle
Volume65
Issue number9-10
Publication statusPublished - Sep 30 2012

Fingerprint

Hungary
Health Care Costs
Health Status
Multiple Sclerosis
Costs and Cost Analysis
Patient Acceptance of Health Care
Eastern Europe
Pensions
Neurology
Pharmaceutical Preparations
Patient Care
Outpatients
Cross-Sectional Studies
Quality of Life

Keywords

  • Cost of illness
  • Health status
  • Hungary
  • Multiple sclerosis

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Health status and costs of ambulatory patients with multiple sclerosis in Hungary. / Péntek, Márta; Gulácsi, L.; Rózsa, C.; Simó, Magdolna; Iljicsov, Anna; Komoly, S.; Brodszky, Valentin.

In: Ideggyógyászati szemle, Vol. 65, No. 9-10, 30.09.2012, p. 316-324.

Research output: Contribution to journalArticle

Péntek, Márta ; Gulácsi, L. ; Rózsa, C. ; Simó, Magdolna ; Iljicsov, Anna ; Komoly, S. ; Brodszky, Valentin. / Health status and costs of ambulatory patients with multiple sclerosis in Hungary. In: Ideggyógyászati szemle. 2012 ; Vol. 65, No. 9-10. pp. 316-324.
@article{bfbf9df75a564033a18897a0c70e8f5a,
title = "Health status and costs of ambulatory patients with multiple sclerosis in Hungary",
abstract = "Background and purpose - Data on disease burden of multiple sclerosis from Eastern-Central Europe are very limited. Our aim was to explore the quality of life, resource utilisation and costs of ambulating patients with multiple sclerosis in Hungary. Methods - Cross-sectional questionnaire survey was performed in two outpatient neurology centres in 2009. Clinical history, health care utilisation in the past 12 months were surveyed, the Expanded Disability Status Scale and the EQ-5D questionnaires were applied. Cost calculation was conducted from the societal perspective. Results - Sixty-eight patients (female 70.6{\%}) aged 38.0 (SD 9.1) with disease duration of 7.8 (SD 6.7) years were involved. Fifty-five (80.9{\%}) had relapsing-remitting form and 52 (76.5{\%}) were taking immunomodulatory drug. The average scores were: Expanded Disability Status Scale 1.9 (SD 1.7), EQ-5D 0.67 (SD 0.28). Mean total cost amounted to 10 902 Euros/patient/year (direct medical 67{\%}, direct non-medical 13{\%}, indirect costs 20{\%}). Drugs, disability pension and informal care were the highest cost items. Costs of mild (Expanded Disability Status Scale 0-3.5) and moderate (Expanded Disability Status Scale 4.0-6.5) disease were 9 218 and 17 634 Euros/patient/year respectively (p",
keywords = "Cost of illness, Health status, Hungary, Multiple sclerosis",
author = "M{\'a}rta P{\'e}ntek and L. Gul{\'a}csi and C. R{\'o}zsa and Magdolna Sim{\'o} and Anna Iljicsov and S. Komoly and Valentin Brodszky",
year = "2012",
month = "9",
day = "30",
language = "English",
volume = "65",
pages = "316--324",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "9-10",

}

TY - JOUR

T1 - Health status and costs of ambulatory patients with multiple sclerosis in Hungary

AU - Péntek, Márta

AU - Gulácsi, L.

AU - Rózsa, C.

AU - Simó, Magdolna

AU - Iljicsov, Anna

AU - Komoly, S.

AU - Brodszky, Valentin

PY - 2012/9/30

Y1 - 2012/9/30

N2 - Background and purpose - Data on disease burden of multiple sclerosis from Eastern-Central Europe are very limited. Our aim was to explore the quality of life, resource utilisation and costs of ambulating patients with multiple sclerosis in Hungary. Methods - Cross-sectional questionnaire survey was performed in two outpatient neurology centres in 2009. Clinical history, health care utilisation in the past 12 months were surveyed, the Expanded Disability Status Scale and the EQ-5D questionnaires were applied. Cost calculation was conducted from the societal perspective. Results - Sixty-eight patients (female 70.6%) aged 38.0 (SD 9.1) with disease duration of 7.8 (SD 6.7) years were involved. Fifty-five (80.9%) had relapsing-remitting form and 52 (76.5%) were taking immunomodulatory drug. The average scores were: Expanded Disability Status Scale 1.9 (SD 1.7), EQ-5D 0.67 (SD 0.28). Mean total cost amounted to 10 902 Euros/patient/year (direct medical 67%, direct non-medical 13%, indirect costs 20%). Drugs, disability pension and informal care were the highest cost items. Costs of mild (Expanded Disability Status Scale 0-3.5) and moderate (Expanded Disability Status Scale 4.0-6.5) disease were 9 218 and 17 634 Euros/patient/year respectively (p

AB - Background and purpose - Data on disease burden of multiple sclerosis from Eastern-Central Europe are very limited. Our aim was to explore the quality of life, resource utilisation and costs of ambulating patients with multiple sclerosis in Hungary. Methods - Cross-sectional questionnaire survey was performed in two outpatient neurology centres in 2009. Clinical history, health care utilisation in the past 12 months were surveyed, the Expanded Disability Status Scale and the EQ-5D questionnaires were applied. Cost calculation was conducted from the societal perspective. Results - Sixty-eight patients (female 70.6%) aged 38.0 (SD 9.1) with disease duration of 7.8 (SD 6.7) years were involved. Fifty-five (80.9%) had relapsing-remitting form and 52 (76.5%) were taking immunomodulatory drug. The average scores were: Expanded Disability Status Scale 1.9 (SD 1.7), EQ-5D 0.67 (SD 0.28). Mean total cost amounted to 10 902 Euros/patient/year (direct medical 67%, direct non-medical 13%, indirect costs 20%). Drugs, disability pension and informal care were the highest cost items. Costs of mild (Expanded Disability Status Scale 0-3.5) and moderate (Expanded Disability Status Scale 4.0-6.5) disease were 9 218 and 17 634 Euros/patient/year respectively (p

KW - Cost of illness

KW - Health status

KW - Hungary

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=84868310731&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868310731&partnerID=8YFLogxK

M3 - Article

C2 - 23126217

AN - SCOPUS:84868310731

VL - 65

SP - 316

EP - 324

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 9-10

ER -